Oak Park, IL is a clinical research site located in Oak Park, Illinois, United States 60304.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Oak Park, IL has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Diabetic Macular Edema (DME).
Sponsors: EyeBiotech Ltd..
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Oak Park, IL has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Oak Park, IL has 1 clinical trials on record, with 1 currently active. Their work covers Diabetic Macular Edema (DME).
Oak Park, IL has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.